PRICE T ROWE ASSOCIATES INC /MD/ - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$172
+11.0%
47,968
+14.6%
0.00%
Q2 2023$155
+17.4%
41,867
+5.3%
0.00%
Q1 2023$132
+7.3%
39,749
+24.9%
0.00%
Q4 2022$123
-99.8%
31,829
+10.4%
0.00%
Q3 2022$71,000
+102.9%
28,843
+62.6%
0.00%
Q2 2022$35,00017,7340.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,793,321$32,447,35411.70%
Velan Capital Investment Management LP 2,726,051$10,059,1289.34%
Altium Capital Management LP 2,380,000$8,782,2006.65%
AWM Investment Company, Inc. 6,017,572$22,204,8413.01%
Caligan Partners LP 847,513$3,127,3231.76%
Perceptive Advisors 11,900,255$43,911,9411.27%
Mesirow Financial Investment Management, Inc. 51,686$190,7210.81%
OBERWEIS ASSET MANAGEMENT INC/ 1,668,700$6,157,5030.75%
TANG CAPITAL MANAGEMENT LLC 1,260,000$4,649,4000.68%
EAM Investors, LLC 883,842$3,261,3770.60%
View complete list of ADMA BIOLOGICS INC shareholders